Preference of Tegaserod vs. PEG 3350 in Patients With Constipation

Completed · Phase 4

Conditions studied: Constipation

In brief

To determine whether female patients have a preference for tegaserod of PEG 3350 relative to dosage form, convenience, ease of administration and taste

Key facts

Study ID
NCT00171522
Run by
Novartis
People needed
52
Starts
2005-05-01
Expected to finish
2005-09-01
Last updated by the study team
2016-03-03

Who can join

Age: 18 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.